Consolidated Balance Sheets (USD $)	Mar. 31, 2012	Dec. 31, 2011
Current assets
Cash	$ 171,732	$ 61,266
Accounts receivable	1,552	17,557
Inventories	517,729	526,284
Deferred financing cost	15,451	49,451
Prepaid expenses and other current assets	186,876	140,336
Total current assets	893,340	794,894
Fixed assets, net of accumulated depreciation of $489	3,760	2,748
Intellectual property	2,000,000	2,000,000
Security deposits	0	10,000
Total assets	2,897,100	2,807,642
Current liabilities
Accounts payable and accrued expenses	274,291	411,665
Note payable for acquisition of intellectual property	0	350,000
Convertible notes payable	400,000	400,000
Accrued interest	26,267	18,400
Accounts payable and accrued expenses - related parties	120,295	132,934
Loans payable	0	60,000
Notes payable - directors	99,500	80,000
Note payable	7,500	7,500
Total current liabilities	927,853	1,460,499
Derivatives liability	894,098	872,659
Total liabilities	1,821,951	2,333,158
Stockholders' equity
Preferred stock, $.001 par value; 25,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value, 300,000,000 shares authorized; 77,588,997 shares issued and outstanding at March 31, 2012 66,813,997 shares issued and outstanding at December 31, 2011	77,589	66,814
Additional paid-in capital	7,227,657	6,138,916
Deficit accumulated during development stage	(6,230,097)	(5,731,246)
Total stockholders' equity	1,075,149	474,484
Total liabilities and stockholders' equity	$ 2,897,100	$ 2,807,642